5,10-Methylene tetrahydrofolate (THF) is required for the synthesis of nucleic acids and is reduced to 5-methyl THF by methylene THF reductase, a flavin-dependent enzyme that uses NADPH as a cofactor
clearing the confusion"
So through those deals, BPC-157 ended up inside a giant generics company that had little interest in pushing an unproven peptide through the rest of clinical testing, and it got shelved)
Self-inject into your mid-thigh quadriceps for easy access and safety, or ask someone to inject into your deltoid/shoulder, and ensure you're reaching muscle tissue, not just subcutaneous fat, for optimal results
Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume
(2010) and Chang et al
